MedicaidPrior AuthMedium impact
Cyramza (ramucirumab) (New)
Humana·LA · Oncology, Hematology·Medicaid
Effective date
Mar 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicaid Louisiana has established a new prior authorization policy for Cyramza (ramucirumab) IV solution covering six cancer indications including esophageal, colorectal, non-small cell lung, gastric, and hepatocellular cancers. The policy requires specific diagnostic criteria and treatment line requirements for coverage approval.
Action Required
By March 1, 2026: Billing team must implement prior authorization requirements for Cyramza (ramucirumab) IV solution for Louisiana Medicaid patients. Update billing system to flag these claims and create workflow to obtain prior auth before treatment. Providers must document specific cancer diagnosis, treatment history, and combination therapy details per policy criteria. Claims submitted without prior authorization will be denied.